Trial tests pill to tame nausea from popular Weight-Loss shots
NCT ID NCT06500429
Summary
This study tested if a new oral medication called NG101 can help manage common stomach side effects, like nausea and vomiting, that people often get from GLP-1 weight-loss drugs like semaglutide. About 120 healthy adults with a body mass index (BMI) between 22 and 35 received a single shot of semaglutide and then took either NG101 or a placebo pill for 5 days. Researchers compared the two groups to see if NG101 was safe and if it reduced the number and severity of stomach-related side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT AND OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Celerion
Tempe, Arizona, 85283, United States
Conditions
Explore the condition pages connected to this study.